The U.S. Department of Agriculture has given a conditional approval to Zoetis to use its bird flu vaccine in poultry, the ...

The eraspec fuel analyzer's “Automatic Fuel Recognition” (AFR) Module makes it simple to measure unknown samples. It automatically initiates the appropriate analysis based on the registered fuel type ...

Babson's end-to-end BetterWay testing ecosystem, which includes the BD MiniDraw Capillary Blood Collection device as well as Babson's proprietary automated sample preparation and preanalytical ...

Megakaryocytes form a three-dimensional (3D) cage composed of laminin and collagen IV connected to the basement membrane surrounding them. This microarchitecture stabilizes megakaryocytes within their ...

An at-home testosterone test can help people monitor their testosterone levels. The best at-home testosterone test on our list is the Everlywell Testosterone Test due to its easy-to-use kit and ...

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...

Prostate cancer has proved an elusive target for cancer immunotherapies, and Merck & Co's checkpoint inhibitor Keytruda is the latest to fall short in the disease in a phase 3 trial. Merck has ...

Find out more about how we test. PageSpeed Insights is a developer tool provider by Google and powered by their Lighthouse platform, which is also available through the Chrome browser as well as ...

Moderna's recent stumbles make the company an acquisition target. Merck desperately needs Moderna's mRNA-based Personal Cancer Vaccines ("PCVs") to extend KEYTRUDA's patent protection beyond 2028.

Garcia was on hand to answer questions from users, such as when she got her fallopian tubes removed (September) and why she took a test in the first place. "I felt weird and sick. I know my body ...

Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los Angeles court next week ...